Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1986 Feb;55(2):176–180. doi: 10.1136/hrt.55.2.176

Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. A placebo controlled study.

L K Toivonen, M S Nieminen, V Manninen, M H Frick
PMCID: PMC1232114  PMID: 3510642

Abstract

The efficacy of pirmenol (a class I antiarrhythmic agent) as a converter of paroxysmal atrial fibrillation was investigated. Forty patients without congestive heart failure or a history of sinus node disorder were randomly allocated to receive either intravenous pirmenol (50-100 mg) or placebo in a double blind trial. In 12 of 20 patients sinus rhythm was restored 2-16 minutes after pirmenol, and in 3 of 20 patients in the control group it returned within one hour. A nodal escape rhythm was seen during sinus slowing in one patient, but in other patients there was no sinus arrest, atrioventricular conduction disturbance, or hypotension. The ventricular rate was slightly increased in patients in whom sinus rhythm was not restored by pirmenol. The results indicate that pirmenol has an antifibrillatory effect on the atria. Sinus rhythm was restored rapidly after intravenous administration. It was well tolerated in patients with atrial fibrillation of recent onset.

Full text

PDF
176

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Lutz J. R., Nappi J. M. Pirmenol for control of ventricular arrhythmias: oral dose-ranging and short-term maintenance study. Am J Cardiol. 1984 Feb 1;53(4):522–527. doi: 10.1016/0002-9149(84)90024-9. [DOI] [PubMed] [Google Scholar]
  2. Aronow W. S., Landa D., Plasencia G., Wong R., Karlsberg R. P., Ferlinz J. Verapamil in atrial fibrillation and atrial flutter. Clin Pharmacol Ther. 1979 Nov;26(5):578–583. doi: 10.1002/cpt1979265578. [DOI] [PubMed] [Google Scholar]
  3. Camm J., Ward D., Spurrell R. A. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias. Br J Clin Pharmacol. 1979 Nov;8(5):441–449. doi: 10.1111/j.1365-2125.1979.tb01023.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dhingra R. C., Deedwania P. C., Cummings J. M., Amat-Y-Leon F., Wu D., Denes P., Rosen K. M. Electrophysiologic effects of lidocaine on sinus node and atrium in patients with and without sinoatrial dysfunction. Circulation. 1978 Mar;57(3):448–454. doi: 10.1161/01.cir.57.3.448. [DOI] [PubMed] [Google Scholar]
  5. Fenster P. E., Comess K. A., Marsh R., Katzenberg C., Hager W. D. Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusion. Am Heart J. 1983 Sep;106(3):501–504. doi: 10.1016/0002-8703(83)90692-0. [DOI] [PubMed] [Google Scholar]
  6. Goldberg D., Reiffel J. A., Davis J. C., Gang E., Livelli F., Bigger J. T., Jr Electrophysiologic effects of procainamide on sinus function in patients with and without sinus node disease. Am Heart J. 1982 Jan;103(1):75–79. doi: 10.1016/0002-8703(82)90532-4. [DOI] [PubMed] [Google Scholar]
  7. Goy J. J., Grbic M., Hurni M., Finci L., Maendly R., Duc J., Sigwart U. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide. Eur Heart J. 1985 Jun;6(6):518–524. doi: 10.1093/oxfordjournals.eurheartj.a061897. [DOI] [PubMed] [Google Scholar]
  8. Halpern S. W., Ellrodt G., Singh B. N., Mandel W. J. Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size. Br Heart J. 1980 Nov;44(5):589–595. doi: 10.1136/hrt.44.5.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hammill S. C., Shand D. G., Routledge P. A., Hindman M. C., Baker J. T., Pritchett E. L. Pirmenol, a new antiarrhythmic agent: initial study of efficacy, safety and pharmacokinetics. Circulation. 1982 Feb;65(2):369–375. doi: 10.1161/01.cir.65.2.369. [DOI] [PubMed] [Google Scholar]
  10. Heng M. K., Singh B. N., Roche A. H., Norris R. M., Mercer C. J. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram. Am Heart J. 1975 Oct;90(4):487–498. doi: 10.1016/0002-8703(75)90431-7. [DOI] [PubMed] [Google Scholar]
  11. Henry W. L., Morganroth J., Pearlman A. S., Clark C. E., Redwood D. R., Itscoitz S. B., Epstein S. E. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation. 1976 Feb;53(2):273–279. doi: 10.1161/01.cir.53.2.273. [DOI] [PubMed] [Google Scholar]
  12. Janse M. J. Influence of the direction of the atrial wave front on A-V nodal transmission in isolated hearts of rabbits. Circ Res. 1969 Oct;25(4):439–449. doi: 10.1161/01.res.25.4.439. [DOI] [PubMed] [Google Scholar]
  13. Mazgalev T., Dreifus L. S., Bianchi J., Michelson E. L. Atrioventricular nodal conduction during atrial fibrillation in rabbit heart. Am J Physiol. 1982 Nov;243(5):H754–H760. doi: 10.1152/ajpheart.1982.243.5.H754. [DOI] [PubMed] [Google Scholar]
  14. Phillips H. R., Stack R. S., Davis D. D., Morris K. G., Lee K. L., Shand D. G., Pritchett E. L. Hemodynamic effects of the antiarrhythmic drug pirmenol. Clin Pharmacol Ther. 1982 Aug;32(2):235–239. doi: 10.1038/clpt.1982.153. [DOI] [PubMed] [Google Scholar]
  15. Reder R. F., Danilo P., Jr, Rosen M. R. Effects of pirmenol HCl on electrophysiologic properties of cardiac Purkinje fibers. Eur J Pharmacol. 1980 Feb;61(4):321–333. doi: 10.1016/0014-2999(80)90071-0. [DOI] [PubMed] [Google Scholar]
  16. Roelandt J., Gibson D. G. Recommendations for standardization of measurements from M-mode echocardiograms. Eur Heart J. 1980 Oct;1(5):375–378. doi: 10.1093/eurheartj/1.5.375. [DOI] [PubMed] [Google Scholar]
  17. Steffe T. J., Mertz T. E., Hastings S. G., Potoczak R. E., Kaplan H. R. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent. J Pharmacol Exp Ther. 1980 Jul;214(1):50–57. [PubMed] [Google Scholar]
  18. Stern S. Treatment and prevention of cardiac arrhythmias with propranolol and quinidine. Br Heart J. 1971 Jul;33(4):522–525. doi: 10.1136/hrt.33.4.522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Strasberg B., Arditti A., Sclarovsky S., Lewin R. F., Buimovici B., Agmon J. Efficacy of intravenous amiodarone in the management of paroxysmal or new atrial fibrillation with fast ventricular response. Int J Cardiol. 1985 Jan;7(1):47–58. doi: 10.1016/0167-5273(85)90172-x. [DOI] [PubMed] [Google Scholar]
  20. Tsuchioka Y., Mitsuda H., Eno S., Fujitani K., Furuta Y., Yoshida M., Miyoshi A., Tateishi H., Satou H. Electrophysiological effects of disopyramide phosphate in patients with sinus node dysfunction. Jpn Circ J. 1982 Jul;46(7):693–700. doi: 10.1253/jcj.46.693. [DOI] [PubMed] [Google Scholar]
  21. Waxman H. L., Myerburg R. J., Appel R., Sung R. J. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study. Ann Intern Med. 1981 Jan;94(1):1–6. doi: 10.7326/0003-4819-94-1-1. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES